These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
950 related items for PubMed ID: 7180558
21. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients. Iqbal MJ, Young MA, Charles J, Elgart B, Von Greiff H, Simpson GM. J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285 [Abstract] [Full Text] [Related]
22. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia. Leong OK, Wong KE, Tay WK, Gill RC. Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796 [Abstract] [Full Text] [Related]
23. Movement disorders in patients treated with long-acting injectable antipsychotic drugs. Bransgrove LL, Kelly MW. Am J Hosp Pharm; 1994 Apr 01; 51(7):895-9. PubMed ID: 7912473 [Abstract] [Full Text] [Related]
24. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients. Inderbitzin LB, Lewine RR, Scheller-Gilkey G, Swofford CD, Egan GJ, Gloersen BA, Vidanagama BP, Waternaux C. Am J Psychiatry; 1994 Dec 01; 151(12):1753-9. PubMed ID: 7977881 [Abstract] [Full Text] [Related]
34. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. Chouinard G, Safadi G, Beauclair L. J Clin Psychopharmacol; 1994 Dec 01; 14(6):377-84. PubMed ID: 7884017 [Abstract] [Full Text] [Related]
35. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels. Jayaram G, Coyle J, Tune L. J Clin Psychiatry; 1986 May 01; 47(5):247-8. PubMed ID: 3700342 [Abstract] [Full Text] [Related]
37. [Evaluation of the efficacy of haloperidol decanoate]. Alvarez JV, Li Gambi M. Acta Psiquiatr Psicol Am Lat; 1986 Sep 01; 32(3):233-6. PubMed ID: 2884807 [Abstract] [Full Text] [Related]
38. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate]. Auch W. Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981 [No Abstract] [Full Text] [Related]
39. The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate. Leff JP, Tress KH. Int Clin Psychopharmacol; 1986 Jul 10; 1 Suppl 1():27-40. PubMed ID: 3559160 [Abstract] [Full Text] [Related]
40. [Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia]. Morasiewicz J, Baranowski P, Borys J, Jańska-Skomorowska M, Kiejna A. Psychiatr Pol; 1995 Jul 10; 29(3):405-20. PubMed ID: 7652093 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]